{"transactions":[{"id":929918,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":881,"price":8.4607,"value":7453.8767,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F5","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22."}],"balance_after":145167,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929917,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":2226,"price":8.4607,"value":18833.5182,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25."}],"balance_after":146048,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929916,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":695,"price":8.4607,"value":5880.1865,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":148274,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929915,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":1114,"price":8.4607,"value":9425.2198,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":148969,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":929914,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-28T02:35:04.000Z","date":"2026-01-27","kind":"sale","planned":false,"acquired":false,"shares":2226,"price":8.4607,"value":18833.5182,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":150083,"source":{"system":"sec-edgar","filing":"0001193125-26-025302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526025302/ownership.xml","form_type":"4"}},{"id":946215,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Option to purchase common stock","published_at":"2026-01-06T21:30:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":42500,"derivative":{"exercise_price":10.335,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001193125-26-004569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004569/ownership.xml","form_type":"4"}},{"id":946214,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 802 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":152309,"source":{"system":"sec-edgar","filing":"0001193125-26-004569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526004569/ownership.xml","form_type":"4"}},{"id":998801,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:05.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":4539,"price":11.1769,"value":50731.9491,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":130257,"source":{"system":"sec-edgar","filing":"0001193125-25-283562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283562/ownership.xml","form_type":"4"}},{"id":998800,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:05.000Z","date":"2025-11-13","kind":"grant","planned":false,"acquired":true,"shares":24967,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":134796,"source":{"system":"sec-edgar","filing":"0001193125-25-283562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525283562/ownership.xml","form_type":"4"}},{"id":1031155,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:02.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":4541,"price":8.9422,"value":40606.5302,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units (\"PSUs\") granted to the Reporting Person on May 31, 2023.  Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on September 27, 2025, resulting in the vesting of 1/6th of the underlying shares."}],"balance_after":109829,"source":{"system":"sec-edgar","filing":"0001193125-25-223662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223662/ownership.xml","form_type":"4"}},{"id":1031154,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-09-29T23:30:02.000Z","date":"2025-09-27","kind":"grant","planned":false,"acquired":true,"shares":24966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":114370,"source":{"system":"sec-edgar","filing":"0001193125-25-223662","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312525223662/ownership.xml","form_type":"4"}},{"id":1292966,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":1122,"price":7.8719,"value":8832.2718,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":88193,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1292965,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":699,"price":7.8719,"value":5502.4581,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":89315,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1292964,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":887,"price":7.8719,"value":6982.3753,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22."}],"balance_after":90014,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1292963,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-29T01:54:15.000Z","date":"2025-01-28","kind":"sale","planned":false,"acquired":false,"shares":2241,"price":7.8719,"value":17640.9279,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24."}],"balance_after":90901,"source":{"system":"sec-edgar","filing":"0000950170-25-010137","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025010137/ownership.xml","form_type":"4"}},{"id":1310327,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Option to purchase common stock","published_at":"2025-01-06T21:09:05.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":42500,"derivative":{"exercise_price":8.68,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0000950170-25-002072","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025002072/ownership.xml","form_type":"4"}},{"id":1310326,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-06T21:09:05.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Grant of RSUs. The RSUs vest in full on 1/26/27."}],"balance_after":93142,"source":{"system":"sec-edgar","filing":"0000950170-25-002072","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025002072/ownership.xml","form_type":"4"}},{"id":1310325,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2025-01-06T21:09:05.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,499 shares acquired on May 17, 2024 and 50 shares acquired on November 17, 2024 pursuant to the Issuer's Employee Stock\nPurchase Plan."}],"balance_after":71892,"source":{"system":"sec-edgar","filing":"0000950170-25-002072","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025002072/ownership.xml","form_type":"4"}},{"id":1665067,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2024-01-31T22:30:18.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":963,"price":17.8005,"value":17141.8815,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23."}],"balance_after":48093,"source":{"system":"sec-edgar","filing":"0000950170-24-009496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024009496/ownership.xml","form_type":"4"}},{"id":1665066,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2024-01-31T22:30:18.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":761,"price":17.8005,"value":13546.1805,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22."}],"balance_after":49056,"source":{"system":"sec-edgar","filing":"0000950170-24-009496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024009496/ownership.xml","form_type":"4"}},{"id":1665065,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2024-01-31T22:30:18.000Z","date":"2024-01-29","kind":"sale","planned":false,"acquired":false,"shares":594,"price":17.8005,"value":10573.497,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22."}],"balance_after":49817,"source":{"system":"sec-edgar","filing":"0000950170-24-009496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024009496/ownership.xml","form_type":"4"}},{"id":1687552,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Option to purchase common stock","published_at":"2024-01-04T21:08:02.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":42500,"derivative":{"exercise_price":15.36,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0000950170-24-001850","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024001850/ownership.xml","form_type":"4"}},{"id":1687551,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2024-01-04T21:08:02.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":21250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/25, 1/26/26, 1/26/27 and 1/26/28."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,489 shares acquired on May 17, 2023 and 206 shares acquired on November 17, 2023 pursuant to the Issuer's Employee Stock\nPurchase Plan."}],"balance_after":50411,"source":{"system":"sec-edgar","filing":"0000950170-24-001850","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024001850/ownership.xml","form_type":"4"}},{"id":2003306,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Option to purchase common stock","published_at":"2023-02-21T22:15:01.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":63750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":63750,"derivative":{"exercise_price":11.99,"expiration_date":"2033-02-15","underlying":"Common Stock","underlying_shares":63750},"source":{"system":"sec-edgar","filing":"0001209191-23-011289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011289/doc4.xml","form_type":"4"}},{"id":2003305,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2023-02-21T22:15:01.000Z","date":"2023-02-16","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/24, 1/26/25, 1/26/26 and 1/26/27."}],"balance_after":27466,"source":{"system":"sec-edgar","filing":"0001209191-23-011289","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123011289/doc4.xml","form_type":"4"}},{"id":2040212,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2023-01-31T22:14:39.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":866,"price":13.8902,"value":12028.9132,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F3","text":"Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 2/7/22."}],"balance_after":16841,"source":{"system":"sec-edgar","filing":"0001209191-23-005746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123005746/doc4.xml","form_type":"4"}},{"id":2040211,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2023-01-31T22:14:39.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":682,"price":13.8898,"value":9472.8436,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Sell-to cover for taxes associated with the vesting of RSUs received by the Reporting Person dated 1/26/22."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,806 shares acquired on May 17, 2022 and 1,583 shares acquired on November 17, 2022 pursuant to the Issuer's Employee Stock Purchase Plan."}],"balance_after":17707,"source":{"system":"sec-edgar","filing":"0001209191-23-005746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123005746/doc4.xml","form_type":"4"}},{"id":2406248,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Option to purchase common stock","published_at":"2022-02-09T22:50:35.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":39281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in 48 equal monthly installments commencing on the grant date."}],"balance_after":39281,"derivative":{"exercise_price":13.14,"expiration_date":"2032-02-06","underlying":"Common Stock","underlying_shares":39281},"source":{"system":"sec-edgar","filing":"0001209191-22-008156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122008156/doc4.xml","form_type":"4"}},{"id":2406247,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":68704,"kind":"person","name":"DOYLE THOMAS JAMES","position":1,"cik":"0001910331","reported_name":"DOYLE THOMAS JAMES","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & Accounting"}}],"security":"Common Stock","published_at":"2022-02-09T22:50:35.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":8390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-22-008156","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122008156/doc4.xml","form_type":"4"}}]}